Business Description

The Global HIV/AIDS market was valued at $xx Mn in 2020 and is expected to reach $xx Mn by 2027, at a CAGR of xx%.

There is a growing demand within the global health community to find ways to improve access to diagnostics for HIV without diminishing the quality of patient care. HIV-infected individuals require testing for initial diagnosis, staging, and ongoing monitoring throughout treatment. For low and middle-income country populations it can be a challenge to achieve a timely diagnosis of infants under 18 months, viral load (VL) monitoring, and CD4 staging. The stage of HIV infection can be identified by clinical symptoms and more accurately by laboratory tests. These tests can be used to identify persons at high risk of disease progression, detect asymptomatic patients, and guide clinical decision making such as when to initiate ART and detect treatment failure.

Advances in POC testing for EID, CD4, and VL are likely to bring about significant changes in access to quality health care. At the same time, advances in high-volume testing also are becoming available, allowing cost-effective consolidation of testing in high-volume centers. In addition, a number of modular or open molecular platforms are available. To improve the accessibility of high-quality antiretroviral therapy (ART), there is a growing demand for simple, affordable, reliable, and quality-assured point-of-care (POC) diagnostics.

At the same time, simplifying diagnostic technologies may reduce the cost of diagnosing and monitoring the treatment of people living with HIV without diminishing the quality of care. In addition, rapid tests are emerging that can be used for self-testing, proposed as an additional approach to help to identify people living with HIV not reached by current testing models. As per current guidance from WHO, all reactive self-test must be confirmed, receiving further testing from a trained provider. All the above are key factors that are responsible for the market growth.

The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Global HIV/AIDS Diagnostics Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.

The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

Segment Analysis

Based on product type, the market is segmented into consumables, instruments, and software and services. The consumables segment held a larger share of xx% in 2019 and is expected to grow at a significant CAGR of xx% during the forecast period. The consumables segment includes assays, kits, reagents, and other consumables necessary for testing. The increasing prevalence of HIV/AIDS is in turn growing the demand for these consumables by doctors, physicians, medicals, and other healthcare professionals. Also, the increasing initiatives undertaken by governments to increase awareness about the syndrome are also augmenting the market growth. Various campaigns and check-up camps organized by government and non-government organizations about kits and other consumables are augmenting the market growth.

Based on test type, the CD4 tests segment is expected to account for the largest share. CD4 cell count is the primary indicator to assess the strength of the immune system and overall health and will remain a key parameter in HIV care for establishing baselines for ART initiation and risk stratification, along with monitoring immune recovery through the early stages of ARV clinical management. CD4 testing will also retain an important role in the management of opportunistic infections, drug toxicity, and virological failure. Laboratory-based CD4 platforms account for virtually the entire market for CD4 testing. Laboratory-based CD4 testing has the lowest cost per test of US$ 3–7.

For more information visit@ https://www.maximizemarketresearch.com/market-report/global-hiv-aids-diagnostics-market/84000/

Market Segmentation

The Global HIV/AIDS Diagnostics Market is segmented by-

Product type

• Consumables
• Instruments
• Software’s and Services

Test Type

• Antibody tests
 HIV-1 Screening tests
 HIV-1 confirmatory tests
 HIV-2
 O diagnostic tests
• Viral Load (VL) tests
• CD4 tests
• Others

End user

• Hospitals
• Diagnostic laboratories
• Others

Regional Insights

Global HIV and AIDS Diagnostics Market

Global HIV and AIDS Diagnostics Market1

North America accounted for the largest share of xx% in 2020, the reason being the rising prevalence of HIV/AIDS cases. According to WHO, around 1.1 million people are living with HIV in the United States of America (USA). Well-established healthcare infrastructure, ease of availability is also a key driver affecting the market growth. Investments by key players in this field have boosted the market growth. The rising adoption of technologically advanced diagnostic systems and increasing awareness is rapidly growing the market.

The Asia Pacific is also expected to witness significant growth during the forecast period due to the allocation of a large amount of healthcare expenditure for hospitals.
Key Players operating the Global HIV/AIDS DIAGNOSTICS Market

• Siemens AG
• Roche Diagnostics
• Abbott Laboratories
• Danaher Corporation
• Thermo Fisher Scientific Inc
• Merck KGaA
• Becton
• Dickinson and Company
• Hologic, Inc
• Alere Inc
• Bio-rad Laboratories
• F. Hoffman-La Roche Ltd
• OraSure Technologies, Inc
• Siemens Healthineers
• Chembio Diagnostic Systems

The report also helps in understanding Global HIV/AIDS DIAGNOSTICS Market dynamics, structure by analysing the market segments and project Global HIV/AIDS DIAGNOSTICS Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global HIV/AIDS DIAGNOSTICS Market make the report investor’s guide.

This report submitted by Maximize market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [email protected]

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908

• Reviews & Ratings
• Write a Review